Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLOVER: C. difficile vaccine in older adults
NCT03090191Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2017
- Primary completion
- Dec 2021
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 23
01
Overview
A Phase 3 trial of Clostridium difficile vaccine in Clostridioides difficile infection (CDI), sponsored by Pfizer. Started Mar 2017; status: completed.
02
Drugs
Clostridium difficile vaccine
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT03090191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03090191.